N-(3,4-dimethoxybenzyl)benzenesulfonamide, 98%, 10mg

2-(Methylthio)benzo[d]oxazole, 95.0%, 1g

DL-SULFORAPHANE, 95.0%, 50mg

N-(2,6-Dimethylphenyl)-2-(4-(2-hydroxy-3-(2-methoxyphenoxy)propyl)piperazin-1-yl)acetamide, 95.0%, 25g

4-Fluoro-L-2-phenylglycine>98.0%(HPLC)(T)5g

Plaque magnétique SEKUROKA®, 50 mm x 5 m, 1 Rouleau

tert-Butyl 3-(isopropylamino)azetidine-1-carboxylate, 97%, 100mg

2-(Benzo[d]thiazol-6-yloxy)acetic acid, 95.0%, 250mg

2-Chloro-4-[[2-[[(1R)-1-(hydroxymethyl)-2-methylpropyl]amino]-9-(1-methylethyl)-9H-purin-6-yl]amino]benzoic acid, 98%, 25mg

tert-Butyl 7-bromo-2H-benzo[b][1,4]oxazine-4(3H)-carboxylate, 97%, 100mg

N-Cbz-1,3-Diaminopropane hydrochloride, 95.0%, 25g

4-Fluorobenzoylacetonitrile, 96.0%, 500g

beta-Hydroxyisovaleric Acid>96.0%(GC)(T)5g